These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16186731)

  • 1. 13C-methionine breath test detects distinct hepatic mitochondrial dysfunction in HIV-infected patients with normal serum lactate.
    Banasch M; Goetze O; Hollborn I; Hochdorfer B; Bulut K; Schlottmann R; Hagemann D; Brockmeyer NH; Schmidt WE; Schmitz F
    J Acquir Immune Defic Syndr; 2005 Oct; 40(2):149-54. PubMed ID: 16186731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [13C]Methionine breath test: a novel method to detect antiretroviral drug-related mitochondrial toxicity.
    Milazzo L; Piazza M; Sangaletti O; Gatti N; Cappelletti A; Adorni F; Antinori S; Galli M; Moroni M; Riva A
    J Antimicrob Chemother; 2005 Jan; 55(1):84-9. PubMed ID: 15590719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease- and treatment-related predictors of hepatic mitochondrial dysfunction in chronic HIV infection assessed by non-invasive (13)C-methionine breath test diagnostic.
    Banasch M; Knyhala K; Kollar S; Serova K; Potthoff A; Schlottmann R; Schmidt WE; Brockmeyer NH; Goetze O
    Eur J Med Res; 2008 Sep; 13(9):401-8. PubMed ID: 18948231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depletion of mitochondrial DNA copies/cell in peripheral blood mononuclear cells in HIV-1-infected treatment-naïve patients.
    Maagaard A; Holberg-Petersen M; Kvittingen EA; Sandvik L; Bruun JN
    HIV Med; 2006 Jan; 7(1):53-8. PubMed ID: 16313293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 13C-Methionine breath test detects liver mitochondrial impairment in HIV-infected patients with antiretroviral drug-related hyperlactatemia.
    Milazzo L; Riva A; Sangaletti O; Piazza M; Antinori S; Moroni M
    J Acquir Immune Defic Syndr; 2004 Apr; 35(4):429-32. PubMed ID: 15097162
    [No Abstract]   [Full Text] [Related]  

  • 6. Depletion of mitochondrial DNA in HIV-1-infected patients and its amelioration by antiretroviral therapy.
    Miura T; Goto M; Hosoya N; Odawara T; Kitamura Y; Nakamura T; Iwamoto A
    J Med Virol; 2003 Aug; 70(4):497-505. PubMed ID: 12794710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 13C-methionine breath test detects drug-related hepatic mitochondrial dysfunction in HIV-infected patients.
    Milazzo L; Menzaghi B; Massetto B; Sangaletti O; Riva A
    J Acquir Immune Defic Syndr; 2006 Feb; 41(2):252-3; author reply 253-4. PubMed ID: 16394861
    [No Abstract]   [Full Text] [Related]  

  • 8. Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients.
    Maagaard A; Holberg-Petersen M; Kollberg G; Oldfors A; Sandvik L; Bruun JN
    Antivir Ther; 2006; 11(5):601-8. PubMed ID: 16964828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal effects of hepatitis C virus treatment on hepatic mitochondrial dysfunction assessed by C-methionine breath test.
    Banasch M; Emminghaus R; Ellrichmann M; Schmidt WE; Goetze O
    Aliment Pharmacol Ther; 2008 Aug; 28(4):443-9. PubMed ID: 18513202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of antiretroviral treatment on (13) C-methionine metabolism as a marker of hepatic mitochondrial function: a longitudinal study.
    Banasch M; Frank J; Serova K; Knyhala K; Kollar S; Potthoff A; Brockmeyer NH; Goetze O
    HIV Med; 2011 Jan; 12(1):40-5. PubMed ID: 20500232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The non-invasive (13)C-methionine breath test detects hepatic mitochondrial dysfunction as a marker of disease activity in non-alcoholic steatohepatitis.
    Banasch M; Ellrichmann M; Tannapfel A; Schmidt WE; Goetze O
    Eur J Med Res; 2011 Jun; 16(6):258-64. PubMed ID: 21810560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial assessment in asymptomatic HIV-infected paediatric patients on HAART.
    Morén C; Noguera-Julian A; Rovira N; Garrabou G; Nicolàs M; Cardellach F; Martínez E; Sánchez E; Miró O; Fortuny C
    Antivir Ther; 2011; 16(5):719-24. PubMed ID: 21817193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extensive investigations of mitochondrial DNA genome in treated HIV-infected subjects: beyond mitochondrial DNA depletion.
    McComsey G; Bai RK; Maa JF; Seekins D; Wong LJ
    J Acquir Immune Defic Syndr; 2005 Jun; 39(2):181-8. PubMed ID: 15905734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antioxidants on mitochondrial function in HIV-1-related lipoatrophy: a pilot study.
    Milazzo L; Menzaghi B; Caramma I; Nasi M; Sangaletti O; Cesari M; Zanone Poma B; Cossarizza A; Antinori S; Galli M
    AIDS Res Hum Retroviruses; 2010 Nov; 26(11):1207-14. PubMed ID: 20977356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine.
    Walker UA; Bäuerle J; Laguno M; Murillas J; Mauss S; Schmutz G; Setzer B; Miquel R; Gatell JM; Mallolas J
    Hepatology; 2004 Feb; 39(2):311-7. PubMed ID: 14767983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial oxidative phosphorylation protein levels in peripheral blood mononuclear cells correlate with levels in subcutaneous adipose tissue within samples differing by HIV and lipoatrophy status.
    Shikuma CM; Gerschenson M; Chow D; Libutti DE; Willis JH; Murray J; Capaldi RA; Marusich M
    AIDS Res Hum Retroviruses; 2008 Oct; 24(10):1255-62. PubMed ID: 18844460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment.
    Maagaard A; Holberg-Petersen M; Løvgården G; Holm M; Pettersen FO; Kvale D
    J Infect Dis; 2008 Nov; 198(10):1474-81. PubMed ID: 18851688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients.
    Côté HC; Brumme ZL; Craib KJ; Alexander CS; Wynhoven B; Ting L; Wong H; Harris M; Harrigan PR; O'Shaughnessy MV; Montaner JS
    N Engl J Med; 2002 Mar; 346(11):811-20. PubMed ID: 11893792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial toxicity in the era of HAART: evaluating venous lactate and peripheral blood mitochondrial DNA in HIV-infected patients taking antiretroviral therapy.
    Montaner JS; Côté HC; Harris M; Hogg RS; Yip B; Chan JW; Harrigan PR; O'Shaughnessy MV
    J Acquir Immune Defic Syndr; 2003 Sep; 34 Suppl 1():S85-90. PubMed ID: 14562863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulatory mechanisms compensate for mitochondrial DNA depletion in asymptomatic individuals receiving stavudine plus didanosine.
    Miró O; López S; Rodríguez de la Concepción M; Martínez E; Pedrol E; Garrabou G; Giralt M; Cardellach F; Gatell JM; Vilarroya F; Casademont J
    J Acquir Immune Defic Syndr; 2004 Dec; 37(5):1550-5. PubMed ID: 15577406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.